Latest Articles

Publication Date
PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of pembrolizumab for locally advanced uterine cervical cancer, and durvalumab and olaparib for advanced or recurrent endometrial cancer in Japan - springermedicine.com

PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of pembrolizumab for locally advanced uterine cervical cancer, and durvalumab and olaparib for advanced …

Published: Dec. 28, 2024, 12:47 p.m.
A machine learning-based immune response signature to facilitate prognosis prediction in patients with endometrial cancer | Scientific Reports - Nature.com

A machine learning-based immune response signature to facilitate prognosis prediction in patients with endometrial cancer | Scientific Reports Nature.com

Published: Dec. 28, 2024, 2:37 a.m.
A machine learning-based immune response signature to facilitate prognosis prediction in patients with endometrial cancer - Nature.com

A machine learning-based immune response signature to facilitate prognosis prediction in patients with endometrial cancer Nature.com

Published: Dec. 28, 2024, 2:37 a.m.
Prognosis of premenopausal women with low-risk endometrial cancer but elevated CA125 levels - Frontiers

Prognosis of premenopausal women with low-risk endometrial cancer but elevated CA125 levels Frontiers

Published: Dec. 26, 2024, 4:01 p.m.
Predicting immunotherapy efficacy in endometrial cancer: focus on the tumor microenvironment - Frontiers

Predicting immunotherapy efficacy in endometrial cancer: focus on the tumor microenvironment Frontiers

Published: Dec. 24, 2024, 7:10 p.m.
Research Bolsters Need for Enhanced Surveillance After Radiotherapy for Endometrial Cancer - Oncology Nurse Advisor

Research Bolsters Need for Enhanced Surveillance After Radiotherapy for Endometrial Cancer Oncology Nurse Advisor

Published: Dec. 23, 2024, 5 p.m.
QOL With Shorter RT Equal to Standard in Endometrial Cancer - Medscape

QOL With Shorter RT Equal to Standard in Endometrial Cancer Medscape

Published: Dec. 23, 2024, 1:27 p.m.
Deep learning for endometrial cancer subtyping and predicting tumor mutational burden from histopathological slides - Nature.com

Deep learning for endometrial cancer subtyping and predicting tumor mutational burden from histopathological slides Nature.com

Published: Dec. 21, 2024, 9:20 a.m.
Characterization of shared neoantigens landscape in Mismatch Repair Deficient Endometrial Cancer - Nature.com

Characterization of shared neoantigens landscape in Mismatch Repair Deficient Endometrial Cancer Nature.com

Published: Dec. 20, 2024, 10:34 a.m.
Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without RT for Newly Diagnosed, High-Risk Endometrial Cancer: Results in DMMR Tumors - Medpage Today

Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without RT for Newly Diagnosed, High-Risk Endometrial Cancer: Results in DMMR Tumors Medpage Today

Published: Dec. 18, 2024, 8:16 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!